8-K Announcements
6Material company update
May 12, 2026·SEC
Material company update
May 12, 2026·SEC
Material company update
May 1, 2026·SEC
Arvinas, Inc.(ARVN)Earnings, Financials & Key Ratios
ARVN•NASDAQ
Price updated Jun 19, 2026
AboutArvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.Show more
- Revenue$263M-0.3%
- EBITDA-$110M+55.0%
- Net Income-$81M+59.4%
- EPS (Diluted)-1.28+53.8%
- Gross Margin98.02%-2.0%
- EBITDA Margin-41.77%+54.8%
- Operating Margin-43.75%+53.9%
- Net Margin-30.77%+59.3%
- ROE-16.23%+50.1%
ARVN Key Insights
Arvinas, Inc. (ARVN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 58.9%
- ✓Share count reduced 9.7% through buybacks
- ✓Trading at only 1.1x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 14 (bottom 14%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ARVN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ARVN Price & Volume
Arvinas, Inc. (ARVN) stock price & volume — 10-year historical chart
Loading chart...
ARVN Growth Metrics
Arvinas, Inc. (ARVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years58.93%
3 Years25.96%
TTM-79.06%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-374.89%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-393.94%
Return on Capital
10 Years-33.51%
5 Years-24.77%
3 Years-27.31%
Last Year-15.99%
ARVN Recent Earnings
Arvinas, Inc. (ARVN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.90+5.3%
$0.95
Rev
$16M-6.1%
$17M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$1.10-100.0%
$0.55
Rev
$10M-74.5%
$37M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.48+36.0%
$0.75
Rev
$42M+12.4%
$37M
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$0.84+3.4%
$0.87
Rev
$22M-10.4%
$25M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.90vs $0.95+5.3% | $16Mvs $17M-6.1% |
| Q1 2026 | Feb 24, 2026 | $1.10vs $0.55-100.0% | $10Mvs $37M-74.5% |
| Q4 2025 | Nov 5, 2025 | $0.48vs $0.75+36.0% | $42Mvs $37M+12.4% |
| Q3 2025 | Aug 6, 2025 | $0.84vs $0.87+3.4% | $22Mvs $25M-10.4% |
Based on last 12 quarters of dataView full earnings history →
ARVN Peer Comparison
Arvinas, Inc. (ARVN) competitors in Drug Discovery and Antibody Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 KYMR | 7.38B | 90.43 | -24.51 | -16.72% | -6.12% | -25.02% | 0.05 | |
 PRAX | 8.15B | 282.31 | -20.94 | -100% | -43.02% | 0.00 | ||
 MDGL | 11.66B | 505.75 | -39.36 | 432.05% | -27.32% | -50.15% | 0.59 | |
 PTCT | 6.55B | 78.98 | 10.15 | 114.51% | -22.58% | |||
 RCUS | 2.45B | 24.31 | -7.39 | -4.26% | -156.36% | -68.97% | 0.16 | |
 RVMD | 34.65B | 162.99 | -27.39 | -83.22% | 0.10 | |||
 PFE | 143.46B | 25.22 | 18.54 | -1.65% | 11.83% | 8.34% | 0.78 | |
 BMY | 110.25B | 54.00 | 15.65 | -0.22% | 15.01% | 38.96% | 2.55 |
Compare ARVN vs Peers
Arvinas, Inc. (ARVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ARVN Income Statement
Arvinas, Inc. (ARVN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 7.58M | 14.32M | 42.98M | 25.9M | 53.6M | 131.4M | 78.5M | 263.4M | 262.6M | 89.4M |
Revenue Growth % | 13.64% | 89% | 200.03% | -39.73% | 106.95% | 145.15% | -40.26% | 235.54% | -0.3% | -79.06% |
Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.2M | 2.3M |
COGS % of Revenue | - | - | - | - | - | - | - | - | 1.98% | - |
Gross Profit | 7.58M▲ 0% | 14.32M▲ 89.0% | 42.98M▲ 200.0% | 25.9M▼ 39.7% | 53.6M▲ 106.9% | 131.4M▲ 145.1% | 78.5M▼ 40.3% | 263.4M▲ 235.5% | 257.4M▼ 2.3% | 87.1M▲ 0% |
Gross Margin % | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 98.02% | 97.43% |
Gross Profit Growth % | 13.64% | 89% | 200.03% | -39.73% | 106.95% | 145.15% | -40.26% | 235.54% | -2.28% | - |
Operating Expenses | 32.34M | 58.13M | 94.5M | 146.7M | 242M | 394.6M | 480M | 513.6M | 372.3M | 336.8M |
OpEx % of Revenue | 426.7% | 405.8% | 219.89% | 566.41% | 451.49% | 300.3% | 611.47% | 194.99% | 141.77% | - |
Selling, General & Admin | 3.55M | 12.93M | 27.31M | 38.3M | 61.6M | 79.6M | 100.3M | 165.4M | 89.4M | 86.5M |
SG&A % of Revenue | 46.79% | 90.28% | 63.54% | 147.88% | 114.93% | 60.58% | 127.77% | 62.79% | 34.04% | - |
Research & Development | 28.79M | 45.19M | 67.19M | 108.4M | 180.4M | 315M | 379.7M | 348.2M | 282.9M | 254.4M |
R&D % of Revenue | 379.91% | 315.51% | 156.35% | 418.53% | 336.57% | 239.73% | 483.69% | 132.19% | 107.73% | - |
Other Operating Expenses | 0 | 102.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.6M |
Operating Income | -24.76M▲ 0% | -43.8M▼ 76.9% | -51.52M▼ 17.6% | -120.8M▼ 134.5% | -188.4M▼ 56.0% | -263.2M▼ 39.7% | -401.5M▼ 52.5% | -250.2M▲ 37.7% | -114.9M▲ 54.1% | -249.7M▲ 0% |
Operating Margin % | -326.7% | -305.8% | -119.89% | -466.41% | -351.49% | -200.3% | -511.47% | -94.99% | -43.75% | -279.31% |
Operating Income Growth % | -50.34% | -76.9% | -17.63% | -134.45% | -55.96% | -39.7% | -52.55% | 37.68% | 54.08% | - |
EBITDA | -24.41M | -43.1M | -49.27M | -117.6M | -182.4M | -255M | -394.8M | -243.6M | -109.7M | -245.2M |
EBITDA Margin % | -322.12% | -300.87% | -114.65% | -454.05% | -340.3% | -194.06% | -502.93% | -92.48% | -41.77% | -274.27% |
EBITDA Growth % | -52.27% | -76.53% | -14.33% | -138.68% | -55.1% | -39.8% | -54.82% | 38.3% | 54.97% | -172.75% |
D&A (Non-Cash Add-back) | 347.39K | 706K | 2.25M | 3.2M | 6M | 8.2M | 6.7M | 6.6M | 5.2M | 4.5M |
EBIT | -24M | -41.42M | -70.21M | -120.8M | -188.4M | -263.2M | -401.5M | -250.2M | -80.5M | -236.2M |
Net Interest Income | 151.03K | 2.41M | 4.5M | 3.52M | 1.7M | 12M | 38.8M | 54.8M | 22M | 34.7M |
Interest Income | 201.39K | 2.47M | 4.6M | 3.59M | 1.8M | 12M | 38.8M | 54.8M | 22M | 34.7M |
Interest Expense | 50.36K | 57.44K | 100K | 65K | 100K | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 711.06K | 2.32M | -18.79M | 1.5M | -2.6M | 1.6M | 35.1M | 51.9M | 34.4M | 28.7M |
Pretax Income | -24.05M▲ 0% | -41.48M▼ 72.5% | -70.3M▼ 69.5% | -119.3M▼ 69.7% | -191M▼ 60.1% | -261.6M▼ 37.0% | -366.4M▼ 40.1% | -198.3M▲ 45.9% | -80.5M▲ 59.4% | -221M▲ 0% |
Pretax Margin % | -317.32% | -289.59% | -163.58% | -460.62% | -356.34% | -199.09% | -466.75% | -75.28% | -30.65% | -247.2% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 20.9M | 900K | 600K | 300K | 300K |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -7.99% | -0.25% | -0.3% | -0.37% | -0.14% |
Net Income | -24.05M▲ 0% | -41.48M▼ 72.5% | -70.29M▼ 69.5% | -119.3M▼ 69.7% | -191M▼ 60.1% | -282.5M▼ 47.9% | -367.3M▼ 30.0% | -198.9M▲ 45.8% | -80.8M▲ 59.4% | -221.3M▲ 0% |
Net Margin % | -317.32% | -289.59% | -163.56% | -460.62% | -356.34% | -214.99% | -467.9% | -75.51% | -30.77% | -247.54% |
Net Income Growth % | -67.58% | -72.48% | -69.46% | -69.72% | -60.1% | -47.91% | -30.02% | 45.85% | 59.38% | -374.89% |
Net Income (Continuing) | -24.05M | -41.48M | -70.3M | -119.3M | -191M | -282.5M | -367.3M | -198.9M | -80.8M | -221.3M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.38▲ 0% | -1.31▲ 5.1% | -1.89▼ 44.3% | -3.02▼ 59.8% | -3.82▼ 26.5% | -5.31▼ 39.0% | -6.62▼ 24.7% | -2.77▲ 58.2% | -1.28▲ 53.8% | -3.46▲ 0% |
EPS Growth % | 81.75% | 5.07% | -44.27% | -59.79% | -26.49% | -39.01% | -24.67% | 58.16% | 53.79% | -393.94% |
EPS (Basic) | -1.38 | -1.31 | -1.89 | -3.02 | -3.82 | -5.31 | -6.62 | -2.77 | -1.28 | - |
Diluted Shares Outstanding | 20.73M | 31.63M | 32.93M | 39.53M | 50M | 53.2M | 55.5M | 71.9M | 64.9M | 64M |
Basic Shares Outstanding | 20.73M | 31.63M | 32.93M | 39.53M | 50M | 53.2M | 55.5M | 71.9M | 64.9M | 64M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ARVN Balance Sheet
Arvinas, Inc. (ARVN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 65.53M | 195.68M | 290.88M | 703.1M | 1.55B | 1.24B | 1.28B | 1.07B | 700.7M | 630.7M |
Cash & Short-Term Investments | 39.17M | 187.83M | 280.87M | 688.6M | 1.5B | 1.21B | 1.26B | 1.04B | 685.4M | 614.9M |
Cash Only | 30.91M | 3.19M | 9.21M | 588.4M | 108.3M | 81.3M | 311.7M | 100.5M | 142.9M | 87.3M |
Short-Term Investments | 8.26M | 184.64M | 271.66M | 100.2M | 1.39B | 1.12B | 949.3M | 938.9M | 542.5M | 527.6M |
Accounts Receivable | 26.04M | 5.03M | 6.28M | 8.4M | 25.7M | 8M | 7.2M | 13.7M | 6.4M | 6.4M |
Days Sales Outstanding | 1.25K | 128.22 | 53.34 | 118.38 | 175.01 | 22.22 | 33.48 | 18.98 | 8.9 | 51.75 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 0 | 0 | 0 | 4.5M | 26.9M | 12M | 14.2M | 8.9M | 9.4M |
Total Non-Current Assets | 1.32M | 3.6M | 10.76M | 14.3M | 29.1M | 28.6M | 24.4M | 24.1M | 17.2M | 16.8M |
Property, Plant & Equipment | 1.3M | 3.58M | 10.73M | 14.3M | 16.6M | 17.8M | 14M | 16M | 13.4M | 13.3M |
Fixed Asset Turnover | 5.83x | 4.00x | 4.00x | 1.81x | 3.23x | 7.38x | 5.61x | 16.46x | 19.60x | 6.36x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 20.76K | 20.76K | 26.76K | 0 | 12.5M | 10.8M | 10.4M | 8.1M | 3.8M | 3.5M |
Total Assets | 66.85M▲ 0% | 199.28M▲ 198.1% | 301.64M▲ 51.4% | 717.4M▲ 137.8% | 1.58B▲ 120.5% | 1.27B▼ 19.8% | 1.3B▲ 2.8% | 1.09B▼ 16.3% | 717.9M▼ 34.2% | 647.5M▲ 0% |
Asset Turnover | 0.11x | 0.07x | 0.14x | 0.04x | 0.03x | 0.10x | 0.06x | 0.24x | 0.37x | 0.11x |
Asset Growth % | 76.21% | 198.11% | 51.36% | 137.83% | 120.46% | -19.78% | 2.82% | -16.34% | -34.22% | -126.14% |
Total Current Liabilities | 17.85M | 22.98M | 32.81M | 49.2M | 261.7M | 295.1M | 257.1M | 229.8M | 142.5M | 115.9M |
Accounts Payable | 596.53K | 2.76M | 4.56M | 7.1M | 31.3M | 5.7M | 17.8M | 13.4M | 24.4M | 31.2M |
Days Payables Outstanding | - | - | - | - | - | - | - | - | 1.71K | 3.57K |
Short-Term Debt | 159.26K | 154.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2M |
Deferred Revenue (Current) | 13.55M | 16.07M | 19.98M | 22.2M | 206.2M | 218.6M | 163M | 156.2M | 71.3M | 313.7M |
Other Current Liabilities | 0 | 0 | 5.81M | 9M | 12.4M | 18.7M | 48M | 0 | 17.5M | 21.4M |
Current Ratio | 3.67x | 8.52x | 8.86x | 14.29x | 5.93x | 4.20x | 4.98x | 4.64x | 4.92x | 5.44x |
Quick Ratio | 3.67x | 8.52x | 8.86x | 14.29x | 5.93x | 4.20x | 4.98x | 4.64x | 4.92x | 5.44x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | -3.52K |
Total Non-Current Liabilities | 48.75M | 39.63M | 42.14M | 26M | 538.2M | 408.8M | 387.5M | 299.9M | 141.6M | 144.8M |
Long-Term Debt | 151.12K | 2M | 2M | 2M | 1M | 1M | 800K | 600K | 400K | 300K |
Capital Lease Obligations | 0 | 0 | 1.71M | 1.1M | 2.9M | 2.7M | 500K | 7.3M | 6.8M | 27.9M |
Deferred Tax Liabilities | -61.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 50.89K | 150K | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 0 |
Total Liabilities | 66.6M | 62.61M | 74.96M | 75.2M | 799.9M | 703.9M | 644.6M | 529.7M | 284.1M | 260.7M |
Total Debt | 310.39K | 2.15M | 4.39M | 4.1M | 5M | 5.5M | 3.2M | 9.7M | 8.9M | 8.6M |
Net Debt | -30.6M | -1.04M | -4.82M | -584.3M | -103.3M | -75.8M | -308.5M | -90.8M | -134M | -78.7M |
Debt / Equity | 1.26x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x | 0.02x | 0.02x | 0.02x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.04x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.32x |
Interest Coverage | -476.57x | -721.15x | -702.07x | -1858.46x | -1884.00x | - | - | - | - | - |
Total Equity | 245.87K▲ 0% | 136.67M▲ 55485.1% | 226.69M▲ 65.9% | 642.2M▲ 183.3% | 781.7M▲ 21.7% | 564.9M▼ 27.7% | 660M▲ 16.8% | 561.7M▼ 14.9% | 433.8M▼ 22.8% | 386.8M▲ 0% |
Equity Growth % | -98.98% | 55485.06% | 65.87% | 183.3% | 21.72% | -27.73% | 16.83% | -14.89% | -22.77% | -66.33% |
Book Value per Share | 0.01 | 4.32 | 6.88 | 16.24 | 15.63 | 10.62 | 11.89 | 7.81 | 6.68 | 6.04 |
Total Shareholders' Equity | 245.87K | 136.67M | 226.69M | 642.2M | 781.7M | 564.9M | 660M | 561.7M | 433.8M | 386.8M |
Common Stock | 1.19M | 31.24K | 38.46K | 0 | 0 | 100K | 100K | 100K | 0 | 100K |
Retained Earnings | -62.42M | -302.26M | -372.56M | -491.9M | -682.9M | -965.4M | -1.33B | -1.53B | -1.61B | -1.67B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -91.9M | -91.9M |
Accumulated OCI | -9.75K | -217.72K | 107.58K | 600K | -4.6M | -19.2M | -3.1M | 1M | 1.2M | -400K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ARVN Cash Flow Statement
Arvinas, Inc. (ARVN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 5.11M | -16.12M | -40.63M | -89.76M | 559.4M | -273.5M | -347.8M | -259.3M | -273.8M | -254.1M |
Operating CF Margin % | 67.47% | -112.52% | -94.53% | -346.55% | 1043.66% | -208.14% | -443.06% | -98.44% | -104.27% | - |
Operating CF Growth % | 126.35% | -415.22% | -152.06% | -120.93% | 723.24% | -148.89% | -27.17% | 25.45% | -5.59% | -149.82% |
Net Income | -24.05M | -41.48M | -70.29M | -119.33M | -191M | -282.5M | -367.3M | -198.9M | -80.8M | -221.3M |
Depreciation & Amortization | 347.39K | 706K | 2.25M | 4.02M | 6M | 8.2M | 6.7M | 6.6M | 5.2M | 5M |
Stock-Based Compensation | 245.05K | 11.63M | 20.07M | 30.2M | 57.1M | 75.5M | 71.6M | 88.2M | 44M | 18.8M |
Deferred Taxes | -5.87K | 193.78K | 0 | -395.07K | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 362.07K | 266.03K | 169.17K | 1.69M | 9M | 7.9M | -14.4M | -14.6M | -8.5M | 12.9M |
Working Capital Changes | 28.21M | 12.57M | 7.17M | -5.94M | 678.3M | -82.6M | -44.4M | -140.6M | -233.7M | -69.5M |
Change in Receivables | -25M | 22.22M | 2.78M | -1M | -30.2M | 14M | 800K | -5.7M | 7.3M | 2M |
Change in Inventory | 2.26M | -3.26M | -2.07M | 6.34M | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -969.48K | 2M | 1.61M | 2.04M | 27.9M | 20.2M | 17.3M | -21.2M | -1.7M | -7.7M |
Cash from Investing | 20.87M | -179.67M | -93.1M | 164.25M | -1.31B | 242.8M | 203.5M | 34.7M | 407.6M | 351.8M |
Capital Expenditures | -1.01M | -2.83M | -6.24M | -6.45M | -4.7M | -6.8M | -2.9M | -1.8M | -1.9M | -2.8M |
CapEx % of Revenue | 13.36% | 19.76% | 14.53% | 24.89% | 8.77% | 5.17% | 3.69% | 0.68% | 0.72% | 3.13% |
Acquisitions | 0 | 0 | 86.8M | -395.07M | 0 | 400K | 0 | 100K | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 21.88M | -176.83M | -86.8M | 395.07M | 0 | -400K | 0 | 0 | 0 | 0 |
Cash from Financing | -161.36K | 168.06M | 139.74M | 504.67M | 278.6M | 4.7M | 374.7M | 7.9M | -91.4M | -91.4M |
Debt Issued (Net) | -161.36K | 1.83M | -169.61K | 0 | 0 | 0 | 0 | -400K | -200K | -200K |
Equity Issued (Net) | 0 | 169.58M | 139.91M | 525.6M | 264.6M | 4.7M | 374.7M | 8.3M | -91.2M | -91.2M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -91.9M | -91.9M |
Other Financing | 0 | -3.35M | 0 | -20.93M | 14M | 0 | 0 | 0 | 0 | 0 |
Net Change in Cash | 25.82M▲ 0% | -27.72M▼ 207.4% | 6.02M▲ 121.7% | 579.16M▲ 9519.0% | -475.6M▼ 182.1% | -26M▲ 94.5% | 230.4M▲ 986.2% | -216.7M▼ 194.1% | 42.4M▲ 119.6% | 6.3M▲ 0% |
Free Cash Flow | 4.1M▲ 0% | -18.95M▼ 562.1% | -46.87M▼ 147.4% | -96.2M▼ 105.3% | 554.7M▲ 676.6% | -280.3M▼ 150.5% | -350.7M▼ 25.1% | -261.1M▲ 25.5% | -275.7M▼ 5.6% | -256.9M▲ 0% |
FCF Margin % | 54.11% | -132.28% | -109.06% | -371.45% | 1034.89% | -213.32% | -446.75% | -99.13% | -104.99% | -287.36% |
FCF Growth % | 120.81% | -562.08% | -147.36% | -105.26% | 676.58% | -150.53% | -25.12% | 25.55% | -5.59% | -1.62% |
FCF per Share | 0.20 | -0.60 | -1.42 | -2.43 | 11.09 | -5.27 | -6.32 | -3.63 | -4.25 | -4.01 |
FCF Conversion (FCF/Net Income) | -0.21x | 0.39x | 0.58x | 0.75x | -2.93x | 0.97x | 0.95x | 1.30x | 3.39x | 1.16x |
Interest Paid | 0 | 0 | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 11.1M | 11.1M | 2.3M | 0 | 0 |
ARVN Key Ratios
Arvinas, Inc. (ARVN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -198.12% | -60.59% | -38.69% | -27.46% | -26.83% | -41.96% | -59.97% | -32.56% | -16.23% | -44.39% |
Return on Invested Capital (ROIC) | - | -62.41% | -21.62% | -64.77% | -38.38% | -33.82% | -71.65% | -45.63% | -22.36% | -47.27% |
Gross Margin | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 98.02% | 97.43% |
Net Margin | -317.32% | -289.59% | -163.56% | -460.62% | -356.34% | -214.99% | -467.9% | -75.51% | -30.77% | -247.54% |
Debt / Equity | 1.26x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x | 0.02x | 0.02x | 0.02x |
Interest Coverage | -476.57x | -721.15x | -702.07x | -1858.46x | -1884.00x | - | - | - | - | - |
FCF Conversion | -0.21x | 0.39x | 0.58x | 0.75x | -2.93x | 0.97x | 0.95x | 1.30x | 3.39x | 1.16x |
Revenue Growth | 13.64% | 89% | 200.03% | -39.73% | 106.95% | 145.15% | -40.26% | 235.54% | -0.3% | -79.06% |
Related:ARVN Dividend History·ARVN Revenue History·ARVN Price History·ARVN P/E History·ARVN Financial Ratios·ARVN Institutional Holders
ARVN SEC Filings & Documents
Arvinas, Inc. (ARVN) SEC filings — annual & quarterly reports (10-K, 10-Q)
ARVN Frequently Asked Questions
Arvinas, Inc. (ARVN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Arvinas, Inc. (ARVN) reported $89.4M in revenue for fiscal year 2025. This represents a 1241% increase from $6.7M in 2016.
Arvinas, Inc. (ARVN) saw revenue decline by 0.3% over the past year.
Arvinas, Inc. (ARVN) reported a net loss of $221.3M for fiscal year 2025.
Dividend & Returns
Arvinas, Inc. (ARVN) has a return on equity (ROE) of -16.2%. Negative ROE indicates the company is unprofitable.
Arvinas, Inc. (ARVN) had negative free cash flow of $256.9M in fiscal year 2025, likely due to heavy capital investments.